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  The tubby mouse is characterized by progressive retinal and cochlear degeneration and late-onset 
obesity. These phenotypes are caused by a loss-of-function mutation in the tub gene and are shared 
with several human syndromes, suggesting the importance of tubby protein in central nervous system 
(CNS) functioning. Although evidence suggests that tubby may act as a transcription factor mediating 
G-protein coupled receptor (GPCR) signaling, any downstream gene regulated by tubby has yet to be 
identified. To explore potential target genes of tubby with region-specific transcription patterns in the 
brain, we performed a microarray analysis using the cerebral cortex and hypothalamus of tubby mice. 
We also validated the changes of gene expression level observed with the microarray analysis using 
real-time RT-PCR. We found that expression of erythroid differentiation factor 1 (Erdr1) and caspase 
1 (Casp1) increased, while p21-activated kinase 1 (Pak1) and cholecystokinin 2 receptor (Cck2r) 
expression decreased in the cerebral cortex of tubby mice. In the hypothalamic region, Casp 1 was 
up-regulated and μ-crystallin (CRYM) was down-regulated. Based on the reported functions of the 
differentially expressed genes, these individual or grouped genes may account for the phenotype of 
tubby mice. We discussed how altered expression of genes in tubby mice might be understood as the 
underlying mechanism behind tubby phenotypes.
Key Words: Tubby, Microarray, Gene expression, Cerebral cortex, Hypothalamus
INTRODUCTION
  The tubby mouse, which arose from spontaneous muta-
tion of the tub gene in the Jackson Laboratory, shows char-
acteristic phenotypes including progressive retinal and 
cochlear degeneration, and late-onset obesity with insulin 
resistance due to a loss-of-function mutation in tub 
(Coleman and Eicher, 1990; Ohlemiller et al., 1995; Stubdal 
et al., 2000). Interestingly, the tubby mouse shares its com-
bination of tubby phenotypes with several human syn-
dromes such as Usher’s syndrome (progressive neuro-
sensory deficits) and Bardet Biedl syndrome (late-onset 
obesity and progressive retinal degeneration) (Katsanis et 
al., 2001; Kremer et al., 2006). Despite the importance of 
tubby protein, its functions and regulatory mechanisms are 
only just now beginning to be unraveled at the molecular 
level.
  To date, several clues have suggested possible bio-
chemical and physiological functions of tubby protein. 
Tubby is widely expressed in both the cochlea and retina 
as well as throughout the brain, including the hypothal-
amus, a brain region responsible for energy metabolism and 
possibly related to the obesity phenotype (Kleyn et al., 
1996; Ikeda et al., 1999; Ikeda et al., 2002; Schwartz and 
Porte, 2005). At the cellular level, tubby is localized to the 
plasma membrane by the interaction of its carboxy-termi-
nal domain with phosphorylated inositol lipids in the basal 
state (Santagata et al., 2001). Upon activation of the G-pro-
tein coupled receptor (GPCR) linked to the Gαq protein, 
phospholipase Cβ (PLCβ) is activated by Gαq, and then 
activated PLCβ hydrolyzes PIP2 into IP3, releasing tubby 
from the membrane and inducing its translocation into the 
nucleus (Santagata et al., 2001). In addition, the amino-ter-
minal domain of tubby is able to activate transcription and 
the carboxy-terminus can bind to double-stranded DNA, 
suggesting that tubby might function as a transcription fac-
tor (Boggon et al., 1999). Nonetheless, no genes regulated 
by tubby have been identified so far.
  In the present study, we examined gene expression pat-
terns in the cerebral cortex and hypothalamus of tubby 
mice using microarray analysis to find genes that might 
be differentially expressed and related to tubby phenotypes. 
We employed real-time RT-PCR to validate candidate genes 
found in the microarray analysis. Ultimately, we identified 
multiple genes that were up- or down-regulated in tubby 
mice, reflecting their potential involvement in expressing 
tubby phenotypes. 
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Table 1. Sequences of primers used in real-time RT-PCR
                   Gene                        Primer sequences 
Erythorid differentiation factor 1 (Erdr1) 
Caspase 1 (Casp 1) 
Tripartite motif protein 3 (Trim3) 
Cholecystokinin 2 receptor (Cck2r) 
Ceroid-lipofuscinosis, neuronal 2 (Cln2) 
START domain containing 10 (Stard10) 
μ-Crystallin (CRYM) 
p21 (CDKN1A)-activated kinase 1 (Pak1) 
Forward: 5'-CGTGGTCAAGATGTCTCTGCCATC 
Reverse: 5'-GGGCATTTCTGTACGCAGTCAGGC 
Forward: 5'-TTCAGTAGCTCTGCGGTGTAGAAA 
Reverse: 5'-AGTTGATAAATTGCTTCCTCTTTGC 
Forward: 5'-TGGTTCCTTCCTGTCCTATATCAAC 
Reverse: 5'-GCCATCCGAGGTCAATGC 
Forward: 5'-GAAGACAGTGATGGCTGCTACGT 
Reverse: 5'-GCGTGGTCAGCGTTGTCAT 
Forward: 5'-TCGGCTAGTGTGGTGATGCA 
Reverse: 5'-GGATGGCCTCAAACTCAGAGACT 
Forward: 5'-ACAAGATCAAGTGTCGGATGGA 
Reverse: 5'-CACTTCTTTCTGTATTCTATGTCATGCA 
Forward: 5'-ATGAGGGCCACAGCAACAC 
Reverse: 5'-TGCTGGGATCAAAGAGAAGCA 
Forward: 5'-GCGTAGACATCCAGGACAAACC 
Reverse: 5'-CTGCCGGCTCCAATCATAGT 
METHODS
Cerebral cortex and hypothalamus collection in tubby 
mice
  Two female and one male B6.Cg-Tubtub/J mice (the 
Jackson Laboratory) at an age of 32 weeks were used. 
Wild-type male mice from the colony of the same age were 
used as control mice. All animals were cared for according 
to NIH guidelines for the use of animals in research. Mice 
were sacrificed by CO2 overdose and whole brains were re-
moved from the skull. The cerebral cortex and hypothal-
amus were isolated according to the protocol (Zapala et al., 
2005). Briefly, each mouse brain was placed ventral side 
up. The hypothalamus was gently pinched out using curved 
forceps, leaving a small depression in the middle of the ven-
tral side. To isolate the cerebral cortex, each mouse brain 
was placed dorsal side up and cut sagittally along the mid-
line, leaving the cerebellum. The cerebral cortex was spread 
apart from the midbrain using two forceps. A portion of 
cerebral cortex was cut away with a scalpel blade. The iso-
lated hypothalamus and cerebral cortex were immediately 
used for RNA preparation. 
Microarray analysis 
  Total RNA was prepared from the cerebral cortex and 
hypothalamus of tubby and control mice using the RNeasy 
lipid tissue mini-kit (Qiagen, Valencia, CA, USA) according 
to the manufacturer’s instructions. RNA samples were proc-
essed for hybridization to the microarray chip and data 
were acquired according to Illumina BeadStation 500X 
manuals. Briefly, biotinylated cRNAs were prepared using 
the Illumina Amplification Kit (Ambion, Austin, USA) and 
hybridized to the Sentrix Mouse Ref-8 v.2 Expression 
BeadChip (＞24,000 probes) (Illumina, San Diego, CA, 
USA) for 16∼18 h at 58oC, according to the manufacturer’s 
instructions. Hybridization signals on the chip were ana-
lyzed by an Illumina bead array confocal scanner and 
Illumina Beadstudio v3.1.3 software (Gene Expression 
Module v3.3.8). The quality of hybridization and overall 
chip performance were monitored by visual inspection of 
both internal quality control checks and the raw scanned 
data. Raw data were transformed by logarithm and normal-
ized by the Quantile Normalization method to remove sys-
tematic bias. Data were statistically analyzed by Avadis 
Prophetic version.3.3 (Strand Genomics, Bangalore, India) 
and presented as the mean of fold change. Genes with ≥ 
2 or ≤−2 fold change in at least two independent compar-
isons among a total of three comparisons were identified. 
The fold change was calculated by dividing the gene ex-
pression level of the mutant by that of the wild-type. For 
the easy recognition of down-regulated genes in tubby mice, 
the negative reciprocals were listed when values were less 
than one (e.g., 0.5 was reported as −2). Among genes dis-
playing sufficient fold changes, those relevant to tubby phe-
notypes were selected and annotated using gene symbols 
and definitions extracted from GenBank records. 
Real-time quantitative reverse transcriptase-polymerase 
chain reaction (RT-PCR)
  cDNA was synthesized by reverse transcription from 2 μg 
of extracted RNA to a final volume of 100 μl using 
Superscript II reverse transcriptase (Invitrogen, Carlsbad, 
CA, USA). The amount of cDNA was measured by real-time 
RT-PCR, as described previously (Lee et al., 2007). Briefly, 
20 μl PCR reactions were set up with 2 μl of synthesized 
cDNA and 10 μl of SYBR Green PCR Master Mix (Applied 
Biosystems, Foster City, CA, USA). The final concentration 
of each primer (Table 1) was 250 nM. PCR was performed 
using an Applied Biosystems 7300 Real-Time PCR System 
(Applied Biosystems, Foster City, CA, USA) using the fol-
lowing cycle conditions: 10 min at 95oC, 40 cycles of 20 sec 
at 95oC and 40 sec at 60oC, and 30 sec at 70oC. Triplicate 
real-time PCR reactions were executed for each sample and 
the obtained Ct values were averaged. According to the 
comparative Ct method, the expression levels of genes were 
presented as a fold change. Results were reported as 
mean±standard error of the mean (S.E.M). The values were 
normalized to β-actin level. Data were analyzed with 
Student’s t-test, and significance was defined as p＜0.05.
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Table 2. A selection of genes up- or down-regulated in the 
cerebral cortex of tubby mice compared to control mice. Gene 
profiling was performed using microarray analysis. Expression 
level is presented as the mean of fold change (n=3). Negative fold
change values indicate decreased gene expression in tubby mice
Regulation 
 in cerebral 
 cortex
Gene Fold change (tubby/cont)
Up
Down
Erythroid differentiation regulator 1 (Erdr1) 
Caspase 1 (Casp1) 
Tripartite motif protein 3 (Trim3)
Cholecystokinin 2 receptor (Cck2r)
Ceroid-lipofuscinosis, neuronal 2 (Cln2) 
p21 (CDKN1A)-activated kinase 1 (Pak1)
  2.44
  2.08
−2.03
−2.21
−2.09
−6.13
Table 3. A selection of genes up- or down-regulated in the 
hypothalamus of tubby mice compared to control mice. Gene 
profiling was performed using microarray analysis. Expression 
level is presented as the mean of fold change (n=3). Negative fold
change values indicate decreased gene expression in tubby mice
Regulation 
in hypo-
thalamus
Gene Fold change (tubby/cont)
Up
Down
Erythroid differentiation regulator 1 (Erdr1) 
Tripartite motif protein 3 (Trim3) 
Cholecystokinin 2 receptor (Cck2r)
Ceroid-lipofuscinosis, neuronal 2 (Cln2) 
START domain containing 10 (Stard10) 
μ-Crystallin (CRYM) 
p21 (CDKN1A)-activated kinase 1 (Pak1) 
  2.84
−2.07
−2.16
−2.20
−2.28
−3.34
−5.12
A
B
Fig. 1. Validation of array-based gene expression profiles in the 
cerebral cortex of tubby mice using real-time RT-PCR. mRNA levels
of genes were determined using real-time RT-PCR. Expression 
profiles of up-regulated (A) and down-regulated genes (B) are 
presented as fold changes compared to the cerebral cortex of control
mice. Expression levels of β-actin were used to normalize the 
values. *p＜0.05 and **p＜0.01.
RESULTS 
Microarray analysis of gene expression in the cerebral 
cortex and hypothalamus of tubby mice
  We dissected the cerebral cortex and hypothalamus from 
the brain of three age-matched pairs of tubby (two female 
and one male tubby mice) and control mice (all male control 
mice) at the age of 32 weeks. In order to compare the tran-
script profiling of these regions, total RNA was isolated and 
processed for microarray analysis. Processed cRNAs were 
hybridized to Illumina chips containing over 24,000 probes 
of mouse genes. Hybridization signals were analyzed and 
the changes in gene expression of each tubby mouse over 
its control mouse were presented as the mean of fold 
change. We screened over 18,000 genes and found 13 genes 
with ≥2-fold change in at least two independent experi-
ments. Among them, we selected eight genes of interest 
that appeared to be related to tubby phenotypes. Five genes 
of interests, namely erythroid differentiation regulator 1 
(Erdr1), tripartite motif protein 3 (Trim 3), cholecystokinin 
2 receptor (Cck2r), ceroid-lipofuscinosis neuronal 2 (Cln2), 
and p21-activated kinase 1 (Pak1), were differentially ex-
pressed in both the cerebral cortex and hypothalamus of 
tubby mice (Table 2 and 3). In contrast, one gene, caspase 
1 (Casp1), was up-regulated only in the cerebral cortex of 
tubby mice (Table 2) and two genes, TART domain contain-
ing 10 (Stard10) and μ-crystallin (CRYM), were down- 
regulated only in the hypothalamus (Table 3). Quantitatively, 
Erdr1 and Casp1 were up-regulated 2.44 and 2.08 fold, re-
spectively, and Trim 3, Cck2r, Cln2, and Pak1 were 
down-regulated 2.03, 2.21, 2.09, and 6.13 fold, respectively, 
in the cerebral cortex of tubby mice compared to control 
mice (Table 2). In the hypothalamus of tubby mice, Erdr1 
was up-regulated 2.84 fold and Trim3, Cck2r, Cln2, 
Stard10, CRYM, and Pak1 were down-regulated 2.07, 2.16, 
2.20, 2.28, 3.34, and 5.12 fold, respectively, compared to 
control mice (Table 3).
Validation of microarray data using real-time RT-PCR
  To validate the reliability of the results obtained from 
the microarray analysis, we performed real-time RT-PCR. 
cDNAs were synthesized from cerebral cortical and hypo-
thalamic RNAs used in the microarray analysis. We de-
signed PCR primers covering all candidate genes (Table 1) 
and performed real-time RT-PCR for all of the genes of in-
terest using cDNAs from both the cerebral cortex and the 
hypothalamus of tubby mice to confirm region-specific ex-
pression patterns. The changes in mRNA levels were pre-
sented as a fold change. For the easy recognition of differ-
entially regulated genes, genes were grouped into up-regu-
lated (upper panel) and down-regulated (lower panel) genes 
primarily based on the findings in the cerebral cortex (Fig. 
1 and 2). We confirmed that Casp1 and Erdr1 were up-regu-
lated 2.47 and 1.95 fold, respectively, and Pak1 and Cck2r 
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A
B
Fig. 2. Validation of array-based gene expression profiles in the 
hypothalamus of tubby mice using real-time RT-PCR. mRNA levels
of genes were determined using real-time RT-PCR. Hypothalamic
Casp1 and Erdr1 expressions (A), the up-regulated genes in the 
cortex, and the expression profiles of other down-regulated genes 
in the hypothalamus (B) are represented as fold changes compared
to the hypothalmus of control mice. Expression levels of β-actin 
were used to normalize the values. *p＜0.05.
were down-regulated −1.28 and −1.20 fold, respectively, 
(28% and 17% lower than the control) in the cerebral cortex 
(Fig. 1). In addition, the expression of Erdr1 increased 2.43 
fold, while CRYM expression decreased −1.72 fold (42% 
lower than the control) in the hypothalamus (Fig. 2). 
However, Stard10, CRYM, Cln2, and Trim3 did not show 
significant alteration of their RNA transcriptions in the cer-
ebral cortex of tubby mice (Fig. 1). In the hypothalamus, 
expression levels of Casp1, Pak1, Stard10, Cln2, Cck2r, and 
Trim3 were not significantly changed (Fig. 2). 
DISCUSSION
  To our knowledge, this is the first attempt to screen ge-
nome-wide gene expression in tubby mice. Using real-time 
RT-PCR to validate genes selected in the microarray analy-
sis, we found that Erdr1, Casp1, Pak1, Cck2r, and CRYM 
were differentially expressed in tubby mice. Although addi-
tional candidate genes were identified in the microarray 
analysis, real-time PCR showed that several genes, such 
as Trim3, Cln2, and Stard10, were false-positives. This dis-
crepancy between microarray and real-time PCR data 
might be due to the low specificity of microarray analysis 
caused by less optimal bioinformatics and algorithms, in-
dicating that real-time PCR remains the gold standard for 
gene expression measurement (Mackay et al., 2002; Wong 
and Medrano, 2005; Wang et al., 2006). In addition, techni-
cal limitations of microarrays can be caused by narrow dy-
namic range, fast signal saturations, and cross-hybrid-
ization, resulting in a certain level of fold change repression 
where fold changes of pair-wise tissues in microarrays are 
usually more depressed than those in real-time PCR (Wang 
et al., 2006). This limitation of microarrays could explain 
why we did not observe the reductions in pro-opiomelano-
cortin (POMC) and neuropeptide Y (NPY) expression in 
tubby mice previously identified by in situ hybridization 
(Guan et al., 1998). Although limitations clearly exist in 
microarray analysis, combining it with real-time PCR vali-
dation enabled us to overcome some of the shortcomings 
and more accurately measure changes in gene expression.
Erythroid differentiation regulator 1 (Erdr 1)
  Among the up-regulated genes, strong increases in Erdr1 
were confirmed by real-time RT-PCR (Fig. 1 and 2) in both 
the cerebral cortex and hypothalamus of tubby mice. Erdr1 
is a secretory protein produced in many tissues, including 
the brain (Dormer et al., 2004b), that induces hemoglobin 
synthesis in erythroleukaemia cell lines and plays a role 
as a stress (e.g. heat, hydrogen peroxide, and trypsin 
etc)-related survival factor in haematopoietic progenitors 
(Dormer et al., 2004a; Dormer et al., 2004b). Erdr1 func-
tions in other tissues remain unclear. 
  In tubby mice, vision and auditory deficits result from 
the progressive degeneration of sensory neurons in the reti-
na and cochlea. The neuroprotective Wlds gene up-regulates 
the expression of an Erdr1-like gene in mice and human 
cells, indicating that Erdr1 might play a role in neuro-
protection (Gillingwater et al., 2006). Further investigation 
is needed to examine how tubby might directly or indirectly 
regulate the increased expression of Erdr1 in response to 
neurodegenerating stress, although the response appears 
insufficient to protect the degeneration of certain types of 
neurons, particularly sensory neurons in the eye and ear, 
in tubby mice. 
Caspase 1 (Casp1)
  The expression of Casp1 was elevated only in the cerebral 
cortex of tubby mice. Casp1 is involved in processing 
pro-IL-1β, stimulating inflammatory processes (Martinon 
et al., 2002). It also mediates apoptosis of neuronal cells 
(Friedlander, 2000). In rats, Casp1 basal activity is higher 
in the hypothalamus than the frontal cortex, and admin-
istration of IL-1β-inducer 3,4-methylenedioxymethamphe-
tamin (ecstasy) increases the activity of Casp1 in the fron-
tal cortex, but not the hypothalamus (Orio et al., 2004; 
O'Shea et al., 2005), indicating that the difference between 
the cerebral cortex and hypothalamus might be a con-
sequence of region-specific activation of different pathways 
leading to Casp1 expression. We also found that Casp1 was 
up-regulated only in the cerebral cortex of tubby mice, and 
not in the hypothalamus.
  The inhibition of Casp1 slows the progression of various 
neurological disorders such as Huntington’s disease and 
traumatic brain injury, and can also regulate the activity 
of caspase 3 (Casp3), another important mediator of apopto-
sis (Friedlander, 2000). The progressive death of photo-
receptors in the retina and ensuing retinal degeneration is 
a typical phenotype of tubby mice (Ikeda et al., 1999; 
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Stubdal et al., 2000). When Casp3 activity is inhibited, reti-
nal degeneration in tubby mice is reduced (Bode and 
Wolfrum, 2003). In addition, light-induced retinal degener-
ation is mediated by a Casp1- and Casp3-dependent mecha-
nism (Perche et al., 2007). Understanding how tubby regu-
lates the expression of Casp1 could inform the exact mecha-
nism of retinal degeneration in tubby mice. 
p21-activated kinase 1 (Pak1)
  Pak1, a serine/threonine protein kinase that mediates 
Rac1 and Cdc42 activity (Bokoch, 2003), has been proposed 
as an important regulator of neuronal polarity, cytoskeletal 
dynamics, and cell migration (Sells et al., 1997; Cau and 
Hall, 2005; Jacobs et al., 2007). Notably, Pak is required 
for regulating axon guidance and targeting of photo-
receptors in Drosophila (Hing et al., 1999). In addition, Pak 
1 has been implicated in the cell survival pathway through 
the direct phosphorylation of the death-promoting Bad pro-
tein, suggesting that Pak 1 could be neuroprotective by pre-
venting the apoptosis of sensory neurons in control mice 
(Schurmann et al., 2000; Tang et al., 2000). Although the 
effect of tubby on axonal guidance or neuronal migration 
has not been studied so far, it would be intriguing to explore 
the role of tubby in regulating expression of Pak 1 and its 
possible involvement in the processes of neuronal migration 
or axonal outgrowth, as well as the degeneration of sensory 
neurons.
Cholecystokinin 2 receptor (Cck2r)
  CCK is a peptide hormone in the gut and brain that plays 
various roles, including the regulation of feeding and diges-
tion through CCK receptors subtype 1 (Cck1r) and 2 
(Cck2r) (Crawley and Corwin, 1994). Cck1r is mostly lo-
calized to the gastrointestinal tract, while Cck2r is abun-
dant in the brain (Hill et al., 1987a; Hill et al., 1987b). 
Obesity with hyperphagia and insulin resistance was re-
cently reported in Cck2r deficient mice (Clerc et al., 2007). 
However, mechanisms of hyperphagia and obesity in Cck2r 
deficient mice are not fully elucidated. Therefore, we cannot 
exclude the possibility that Cck2r activity in brain regions 
other than hypothalamus, a traditional eating center, plays 
a regulatory role in hyperphagia and obesity of tubby mice, 
implying that the decrease of Cck2r expression in the cere-
bral cortex could be meaningful. For example, chol-
ecystokinin induced satiety by interacting through Cck1r 
located in the hindbrain (Chandra and Liddle, 2007). On 
the other hand, the expression level of Cck2r is higher in 
the cerebral cortex than the hypothalamus (Gaudreau et 
al., 1983; Morency et al., 1994). Considering that the ex-
pression level of Cck2r mRNA was slightly decreased (about 
17%) in the cerebral cortex of tubby mice (Fig. 1), it might 
be difficult to see the change in the expression level of 
Cck2r in the hypothalamus of tubby mice due to its low 
expression level and small number of samples in our experi-
ment (Fig. 2). Tubby might have less effect on Cck2r ex-
pression than other candidate genes. However, the de-
creased expression of Cck2r in the cerebral cortex can be 
a clue to reveal an underlying mechanism of obesity in tub-
by mice. Further exploration of the exact mechanism by 
which tubby regulates Cck2r expression is needed.
μ -Crystallin (CRYM)
  CRYM was down-regulated in the tubby mouse 
hypothalamus. CRYM is a nicotinamide adenine dinucleo-
tide phosphate (NADPH)-dependent cytosolic 3,5,3’-triiodo- 
L-thyronine (T3) binding protein expressed in specific tis-
sues including the brain, retina, and inner ear (Segovia et 
al., 1997; Abe et al., 2003; Suzuki et al., 2003). Although 
the exact functions and regulatory mechanisms of CRYM 
are not well understood, it has pivotal roles in organ devel-
opment and cellular differentiation by affecting thyroid hor-
mone concentration, which leads to the modification of thy-
roid hormone action (Suzuki et al., 2007). For example, fam-
ilies with hereditary nonsyndromic deafness carry a muta-
tion of CRYM gene that prevents NADPH-dependent T3 
binding to CRYM and causes severe deafness (Abe et al., 
2003; Oshima et al., 2006). In addition, based on the critical 
role of thyroid hormone in retinal development (Roberts et 
al., 2006) and evidence that CRYM is associated with mac-
ular degeneration of the retina (Umeda et al., 2005), the 
observed down-regulation of CRYM expression in tubby 
mice suggests that CRYM is involved in the progression 
of retinal degeneration. Moreover, thyroid hormone is a pos-
itive regulator of tubby gene expression (Koritschoner et 
al., 2001). It could be that CRYM is down-regulated in the 
absence of tubby protein, leading to a reduction of thyroid 
hormone concentration in the cytoplasm. Accordingly, 
CRYM might be an important molecular link between thy-
roid hormone function and tubby-associated phenotypes, in-
cluding hearing loss and visual dysfunction.
  We used the cerebral cortex and hypothalamus of tubby 
mice for identifying target genes which can be regulated 
by tubby. Although we found several candidate genes in 
those brain tissues, some tubby phenotypes like progressive 
retinal degeneration and hearing loss are localized to the 
retina and cochlear tissue. Therefore, it will be interesting 
to further examine the local changes of candidate genes in 
the retina and cochlear tissues of tubby mice. Especially, 
Casp 1 and CRYM that seem to be related to the retinal 
and cochlear degeneration are worth examining their ex-
pression levels in the retinal and cochlear tissues of tubby 
mice.
  In this study, we identified candidate target genes of tub-
by using microarray analysis and real-time RT-PCR. Based 
on their reported functions, the differentially expressed 
genes that we found are attractive target molecules that 
could be responsible for tubby mouse phenotypes such as 
obesity and retinal and cochlear degeneration. Combined 
with PCR validation, microarray analysis with transgenic 
mice represents a useful tool for identifying unknown down-
stream genes regulated by an interesting protein that in-
duces special phenotypes. Our data provide deeper insight 
into the target genes of tubby protein and the pathogenesis 
of tubby phenotypes. 
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